Researchers at the National Institutes of Health (NIH) and Oregon Health & Science University (OHSU) have found that an experimental vaccine elicits antibodies that can protect nonhuman primates from Ebola virus infection. Ebola virus causes severe hemorrhagic fever in humans and nonhuman primates, meaning that infection may lead to shock, bleeding and multi-organ failure. According to the World Health Organization, Ebola hemorrhagic fever has a fatality rate of up to 90 percent. There is no licensed treatment or vaccine for Ebola virus infection.
Several research groups have developed experimental vaccine approaches that protect nonhuman primates from Ebola virus and the closely related Marburg virus. These approaches include vaccines based on DNA, recombinant adenovirus, virus-like particles, and human parainfluenza virus 3. But how these vaccine candidates confer protection is an area that is still being explored: Do they activate immune cells to kill the invading virus? Or do they elicit antibodies that block infection?
In this study, scientists at NIH's National Institute of Allergy and Infectious Diseases and OHSU's Vaccine & Gene Therapy Institute built on earlier work with an experimental vaccine composed of an attenuated vesicular stomatitis virus carrying a gene that codes for an Ebola virus protein. They observed how cynomolgus macaques responded to a challenge of Ebola virus before and during treatment with the vaccine and in conjunction with depleted levels of immune cells. Their results showed that important immune cells—CD4+ T cells and CD8+ T cells—had a minimal role in providing protection, while antibodies induced by the vaccine appeared to be critical to protecting the animals.
The scientists say this finding will help improve future Ebola virus vaccine development. They plan to focus their studies on what level of antibody production is needed to establish protection from Ebola virus infection in humans
WHO: Heinz Feldmann, M.D., Ph.D., chief of the Laboratory of Virology at NIAID's Rocky Mountain Laboratories. Dr. Feldmann is an expert on viral hemorrhagic fevers and emerging viruses.
ARTICLE: A Marzi et al. Antibodies are necessary for rVSV/ZEBOV-GP mediated protection against lethal Ebola virus challenge in nonhuman primates. Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.1209591110 (2013).
NIH/National Institute of Allergy and Infectious Diseases: http://www.niaid.nih.gov
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Smithsonian photographer Laurie Penland details the exhausting, but rewarding, work of scraping invasive species off the hull of a boat
Politicians who ignore message cannot in future say they take science seriously, open letter says
In the wake of Hurricane Sandy two years ago, shocking photos showed the huge extent of the destruction caused by the storm. Only days after the storm struck, before and after satellite images from Google revealed the widespread damage to coastal areas of New York and New Jersey. Last year, before and after photos showed progress but still a lot of work to be done.
Australian scientists say they have successfully tested a vaccine aimed at protecting wild koalas from chlamydia.
A startup that might have a record-breaking solar cell is in danger of going out of business.The power unit is a rectangular slab about the size of a movie theater screen. It’s mounted on a thick steel post, and equipped with a tracking mechanism that continuously points it at the sun. The slab is made of over 100,000 small lenses and an equal number of even smaller solar cells, each the size of the tip of a ballpoint pen. This contraption is part of one of the most efficient solar power devices ever made.
There are several captive breeding programs for pandas around the world; but one facility in China hopes to release the endangered animals back into the wild
Researchers argue for a nationwide shift to more premium fuel at the pump
Bird watchers' elusive warbler has shifted its summer habitat to pine plantations
One-child policies and plagues that cut the population won't be enough to fix our ecological problems, models suggest. Only changes in consumption will do that
They were down to only 15 about 50 years ago